O | Promethean BioPharma

top of page

Clinical Research

Obesity

An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity

Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation

Hind limb suspension and long-chain omega-3 PUFA increase mRNA
endocannabinoid system levels in skeletal muscle

Pathophysiological role of host microbiota in the development of obesity

The cannabinoid D9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity

The endocannabinoid system in obesity and type 2 diabetes

OCD

Cannabidiol reverses the mCPP-induced increase in marble-burying behavior

Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying
behavior in mice

Optic Function

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys

Organ Transplants

Marijuana Use in Potential Liver Transplant Candidates

Back to Clinical Research

bottom of page